About Certara Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.certara.com/
Frequently Asked Questions
What is the 52-week range for CERT?
The 52-week high is $13.88 and the 52-week low is $4.45.
What is the P/E ratio for CERT?
The P/E ratio data is currently unavailable.
What is the dividend yield for CERT?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -6.66%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -16.75%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.32.
Analyst Recommendation Trends
Wall Street analyst consensus for CERT over the last few months:
Latest CERT News
'HHS launches project to speed up clinical trials' - Axios
https://www.axios.com/2026/09/30/hhs-clinical-trials-redesign
In-Silico Drug Discovery Market Report Now Available: Capitalize on AI-led R&D disruption as revenue surges from $3.3B to $6B by 2030; benchmark Certara, Insilico Medicine, Isomorphic Labs, Exscientia and BenevolentAI to secure share.
AI, cloud and HPC are accelerating virtual screening and precision medicine, expanding adoption across pharma, biotech and CROs in oncology, neurology, rare and infectious diseases.Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "In-Silico Drug Discovery Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global In-Silico Drug Discovery Market to Reach US$6 Billion by 2030 The global in-silico drug discovery market was valued at US$3.3 billion in 2024 and i
UBS Downgrades Certara to Neutral, Maintains Price Target to $10
UBS analyst Kevin Caliendo downgrades Certara (NASDAQ:CERT) from Buy to Neutral and maintains the price target from $10 to $10.
Capitalize on Drug Discovery Informatics: Benchmark Schrödinger, Certara, Dotmatics, Thermo Fisher and BIOVIA to Accelerate R&D ROI and Secure Market Advantage
AI, machine learning and big data are advancing virtual screening and precision medicine, creating opportunities in molecular modeling, docking and data integration.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Drug Discovery Informatics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Drug Discovery Informatics was estimated at US$4.0 Billion in 2025 and is projected to reach US$8.7 Billion by 2032, growing at a CAGR of 11.9% from 2025
Capitalize on Biosimulation’s R&D Disruption: Benchmark Certara, Simulations Plus, Dassault Systèmes, Schrödinger and Applied BioMath to Accelerate Drug Pipelines and Secure ROI
Biosimulation adoption is rising in drug development, driven by AI, personalized medicine, regulatory support and R&D cost savings, with strong opportunities in services and Asia-Pacific.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Biosimulation Technology - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Biosimulation Technology was valued at US$3.6 Billion in 2024 and is projected to reach US$8.5 Billion by 2030, growing at a CAGR of 1
Certara (CERT) Slashes Jobs While Doubling Down On Software Growth
On August 4, Certara (NASDAQ:CERT) reported second-quarter 2026 results that told two different stories at once. Software revenue climbed 4% to $48.8 million, and bookings for that segment jumped 9%, yet the company swung to a $6.1 million net loss just a year after posting a small profit. Layered on top of a completed divestiture, […]
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-01 | Mohammed Faiz | +63,532 | - | - |
| 2026-06-01 | Corcoran Daniel | -14,889 | - | - |
| 2026-06-01 | Corcoran Daniel | -7,941 | - | - |
| 2026-06-01 | Corcoran Daniel | -7,893 | $5.82 | $45,937 |
| 2026-06-01 | Corcoran Daniel | +14,889 | - | - |
| 2026-06-01 | Corcoran Daniel | -4,210 | $5.82 | $24,502 |
| 2026-06-01 | Corcoran Daniel | +7,941 | - | - |
| 2026-06-01 | Anhalt Rona | -7,147 | - | - |
| 2026-06-01 | Anhalt Rona | -2,241 | $5.82 | $13,043 |
| 2026-06-01 | Anhalt Rona | +7,147 | - | - |
| 2026-05-14 | Bedi Arjun | +33,222 | - | - |
| 2026-05-14 | Bedi Arjun | -5,547 | - | - |
| 2026-05-14 | Bedi Arjun | +5,547 | - | - |
| 2026-05-14 | Reynders John V W | +33,222 | - | - |
| 2026-05-14 | Reynders John V W | -15,757 | - | - |
| 2026-05-14 | Reynders John V W | +15,757 | - | - |
| 2026-05-14 | Killefer Nancy | +33,222 | - | - |
| 2026-05-14 | Killefer Nancy | -15,757 | - | - |
| 2026-05-14 | Killefer Nancy | +15,757 | - | - |
| 2026-05-14 | BROSHY ERAN | +33,222 | - | - |
| 2026-05-14 | BROSHY ERAN | -15,757 | - | - |
| 2026-05-14 | BROSHY ERAN | +15,757 | - | - |
| 2026-05-14 | CASHMAN JAMES E III | +33,222 | - | - |
| 2026-05-14 | CASHMAN JAMES E III | -15,757 | - | - |
| 2026-05-14 | CASHMAN JAMES E III | +15,757 | - | - |
| 2026-05-14 | Crane Rosemary A | -15,757 | - | - |
| 2026-05-14 | Crane Rosemary A | +15,757 | - | - |
| 2026-05-14 | Collins Cynthia | -15,757 | - | - |
| 2026-05-14 | Collins Cynthia | +15,757 | - | - |
| 2026-05-14 | WALSH MATTHEW M | +33,222 | - | - |
| 2026-05-14 | WALSH MATTHEW M | -15,757 | - | - |
| 2026-05-14 | WALSH MATTHEW M | +15,757 | - | - |
| 2026-05-11 | Resnick Jon Matthew | -59,766 | - | - |
| 2026-05-11 | Resnick Jon Matthew | +728,405 | - | - |
| 2026-05-11 | Resnick Jon Matthew | +493,827 | - | - |
| 2026-05-11 | Resnick Jon Matthew | +179,299 | - | - |
| 2026-05-11 | Resnick Jon Matthew | +740,740 | - | - |
| 2026-05-11 | Resnick Jon Matthew | +268,949 | - | - |
| 2026-05-11 | Resnick Jon Matthew | -24,377 | $6.31 | $153,819 |
| 2026-05-11 | Resnick Jon Matthew | +59,766 | - | - |
| 2026-05-11 | Corcoran Daniel | +111,111 | - | - |
| 2026-05-11 | Corcoran Daniel | +74,074 | - | - |
| 2026-05-11 | Corcoran Daniel | +48,820 | - | - |
| 2026-05-11 | Corcoran Daniel | -48,820 | - | - |
| 2026-05-11 | Anhalt Rona | +92,592 | - | - |
| 2026-05-11 | Anhalt Rona | +61,728 | - | - |
| 2026-05-11 | Anhalt Rona | +43,938 | - | - |
| 2026-05-11 | Anhalt Rona | -43,938 | - | - |
| 2026-05-11 | Aspbury Robert | +129,629 | - | - |
| 2026-05-11 | Aspbury Robert | +246,913 | - | - |
| 2026-05-11 | Aspbury Robert | +86,419 | - | - |
| 2026-05-11 | Aspbury Robert | +68,348 | - | - |
| 2026-05-11 | Aspbury Robert | -68,348 | - | - |
| 2026-05-11 | Gallagher John E | +194,444 | - | - |
| 2026-05-11 | Gallagher John E | +129,629 | - | - |
| 2026-05-11 | Gallagher John E | +102,522 | - | - |
| 2026-05-11 | Gallagher John E | -102,522 | - | - |
| 2026-05-11 | Pedersen Leif E | +111,111 | - | - |
| 2026-05-11 | Pedersen Leif E | +74,074 | - | - |
| 2026-05-11 | Pedersen Leif E | +68,348 | - | - |
| 2026-05-11 | Pedersen Leif E | -68,348 | - | - |
| 2026-04-01 | McKemey Adrian | -10,849 | - | - |
| 2026-04-01 | McKemey Adrian | -2,642 | $5.7 | $15,059 |
| 2026-04-01 | McKemey Adrian | +10,849 | - | - |
| 2026-04-01 | Corcoran Daniel | -10,849 | - | - |
| 2026-04-01 | Corcoran Daniel | -5,751 | $5.7 | $32,781 |
| 2026-04-01 | Corcoran Daniel | +10,849 | - | - |
| 2026-04-01 | Anhalt Rona | -9,764 | - | - |
| 2026-04-01 | Anhalt Rona | -3,062 | $5.7 | $17,453 |
| 2026-04-01 | Anhalt Rona | +9,764 | - | - |
| 2026-04-01 | Aspbury Robert | -15,188 | - | - |
| 2026-04-01 | Aspbury Robert | -10,127 | - | - |
| 2026-04-01 | Aspbury Robert | -7,852 | - | - |
| 2026-04-01 | Aspbury Robert | -7,139 | $5.7 | $40,692 |
| 2026-04-01 | Aspbury Robert | +15,188 | - | - |
| 2026-04-01 | Aspbury Robert | -4,760 | $5.7 | $27,132 |
| 2026-04-01 | Aspbury Robert | +10,127 | - | - |
| 2026-04-01 | Aspbury Robert | -3,691 | $5.7 | $21,039 |
| 2026-04-01 | Aspbury Robert | +7,852 | - | - |
| 2026-04-01 | Aspbury Robert | -6,821 | $5.7 | $38,880 |
| 2026-04-01 | Aspbury Robert | +14,510 | - | - |
| 2026-04-01 | Gallagher John E | -22,782 | - | - |
| 2026-04-01 | Gallagher John E | -15,190 | - | - |
| 2026-04-01 | Gallagher John E | -12,633 | - | - |
| 2026-04-01 | Gallagher John E | -7,803 | $5.7 | $44,477 |
| 2026-04-01 | Gallagher John E | +22,782 | - | - |
| 2026-04-01 | Gallagher John E | -5,203 | $5.7 | $29,657 |
| 2026-04-01 | Gallagher John E | +15,190 | - | - |
| 2026-04-01 | Gallagher John E | -4,327 | - | - |
| 2026-04-01 | Gallagher John E | +12,633 | - | - |
| 2026-04-01 | Gallagher John E | -7,775 | $5.7 | $44,318 |
| 2026-04-01 | Gallagher John E | +23,346 | - | - |
| 2026-04-01 | Pedersen Leif E | -15,188 | - | - |
| 2026-04-01 | Pedersen Leif E | -10,127 | - | - |
| 2026-04-01 | Pedersen Leif E | -7,852 | - | - |
| 2026-04-01 | Pedersen Leif E | -3,699 | $5.7 | $21,084 |
| 2026-04-01 | Pedersen Leif E | +15,188 | - | - |
| 2026-04-01 | Pedersen Leif E | -2,466 | $5.7 | $14,056 |
| 2026-04-01 | Pedersen Leif E | +10,127 | - | - |
| 2026-04-01 | Pedersen Leif E | -1,912 | $5.7 | $10,898 |
| 2026-04-01 | Pedersen Leif E | +7,852 | - | - |
| 2026-04-01 | Pedersen Leif E | -3,534 | $5.7 | $20,144 |
| 2026-04-01 | Pedersen Leif E | +14,510 | - | - |
| 2026-02-27 | Bedi Arjun | +5,547 | - | - |
| 2025-11-11 | Feehery William F | +24,096 | $8.3 | $199,997 |